Sartorius cuts annual profit margin outlook on lower lab equipment demand
GDANSK, July 18 (Reuters) - Pharmaceuticals supplier
Sartorius SATG.DE STDM.PA cut its 2024 profit margin outlook
on Thursday as it sees lower demand for lab equipment in the
second half of the year.
The German-French company now expects its underlying
earnings before interest, taxes, depreciation and amortisation
(EBITDA) margin to be between 27% and 29%, down from the 30%
expected earlier.
(Reporting by Andrey Sychev; Editing by Kirsten Donovan)
((andrey.sychev@thomsonreuters.com;))
Recent news on Sartorius AG
See all newsEurope Research Roundup: ASML Holding, Douglas, Richemont
Brief: Sartorius Opens Competence Center In Freiburg
Bio‑Rad Laboratories jumps after report Elliott builds stake
Sartorius shares rise after report of Elliott investment
Elliott builds big stake in life-science tools supplier Bio-Rad Labs, WSJ reports (updated)